Intraosseous Infusion Devices Market by Product (B.I.G, FAST1, EZ-IO, FASTR, IO Needles), Route of Administration (Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus, Head of Humerus), Technology (Manual, Automatic), End User & Region - Forecast to 2031 - 2031

Intraosseous Infusion Devices Market Snapshot

[193 Pages Report] According to Future Market Insights (FMI), the global intraosseous infusion device was valued at US$ 3.5 Bn in 2020 and is expected to reach US$ 7.9 Bn by 2031, at a CAGR of 7.6% over the forecast period (2021-2031).  

Amidst soaring competition, Pyng medical Corp., Cook Medical Incorporated, PerSys Medical, Aero Healthcare, Teleflex, Inc., and Beckon Dickinson and Co. have emerged as top market players. FMI has projected these companies to account for over half of the global market share in 2021.     

Market Outlook:

How will the Intraosseous Infusion Market Outlook for 2021-2031 compare to 2016-2020?

According to Future Market Insights (FMI), the sales of the intraosseous infusion device have grown at a CAGR of nearly 5.6% between 2016 and 2020. Increasing research on emergency medical care portfolio globally will result in impressive sales prospects over the coming years.

According to FMI, the intraosseous infusion devices market holds nearly 19% of the US$ 18.5 Bn worth global market for infusion devices. The demand for intraosseous devices will continue increasing through the forecast period. 

For instance, air support for immediate medical emergency services is the new outlook in 911 services and has been appreciated by the other emergency health professionals and the local population.

The upcoming air emergency medical service is to be equipped with a variety of emergency medical devices such as a ventilator, cardiac monitor, burn packs, IV pumps, cervical collars and obstetric kit along with intraosseous infusion devices.

The upcoming policy is expected to drive the intraosseous infusion devices market. Infusion of drugs through the bone using intraosseous devices is more cost-effective and can be done more efficiently as compared to intravenous catheters in hospital settings.

Manufacturers are investing in research and development activities to develop IO devices that can be used in hospital settings to initiate instant care to patients. Mergers and acquisitions together with extensive R&D initiatives for strengthening product portfolio are key strategies adopted by companies to increase their revenue.

For Instance, On Dec 18, Cook Medical Incorporated announced the acquisition of Whitaker Park Development Authority Inc. that once manufactured cigarettes but henceforth will be manufacturing intraosseous infusion devices for better care of the patients.

The market is consolidated and is dominated by players such as include, Pyng medical Corp., Cook Medical Incorporated, PerSys Medical, Aero Healthcare, Teleflex, Inc., and Becton Dickinson and Co.

Future Market Insights expects the global market for intraosseous infusion devices to grow at a CAGR of 7.6% between 2021 and 2031. The growth is attributable to the rising number of research and development activities undertaken by market players to expand their presence and strengthen product portfolios.

Request comprehensive report brochure

How is Rising Demand for Emergency Healthcare Affecting Intraosseous Infusion Devices Market?

IO Devices are designed to maximize efficiency, safety, eliminate unnecessary services and decrease treatment time. A sedentary lifestyle has also determined the growth of the market as it causes various illnesses which incudes, last stage renal diseases, COPD, urological diseases, cardiovascular diseases, etc. Such chronic clinical conditions have brought demand in the vascular access devices in the forecast period.

Emergency medical care is considered as pre-hospital or ambulatory transportation aid for road accident victims and those who have sustained life-threatening injuries for which, immediate medical intervention is required. Lack of structural models in medical aid leads to ineffective medical care. These factors, along with the rising number of emergency cases globally is expected to raise demand for efficient emergency medical services and in turn, is underpinning the intraosseous infusion device market.

According to the American Heart Association report, 2015, compiled with data from the Centers for Disease Control and Prevention, the National Institutes of Health and other government sources, cardiovascular disease is the leading cause for death globally, associated with 17.3 Mn deaths per year, which is further expected to increase to 23.6 Mn by 2030 end.

Vascular access products fill an important void in emergency medical services and contribute significantly towards the annual revenue of various major medical devices manufacturers. The ease and immediate effect through vascular access have helped considerably high number of patients requiring immediate medication intervention.

According to an Elsevier/Journal of Emergency Medical Services (JEMS) editorial supplement sponsored by VidaCare, IO infusion supported vascular access of drugs positively and provided rapid vascular access in 250 patients with a success rate of 97%. The study supports the significance of the need for vascular access and is expected to favour the growth of the intraosseous infusion market shortly

Over the recent years, there has been a significant upsurge in the number of emergency medical cases in response to rising demand from patients, physicians and insurers. Rapid technological advancements have led to various medical procedures being carried out using vascular access devices.

How is The Rising Number of Traumatic Surgeries Affecting Intraosseous Infusion Devices Market Growth?

There are two components involved in community care, care during transportation and care in the healthcare facility. In emergency medical departments a patient can be brought in a severe life threatening condition, be it severe burns, road traffic accidents or cardiac arrest, where sometimes it is difficult to find for an IV point or it becomes difficult when the venous system is collapsed. This in turn is need for intraosseous infusion devices in the market.

A rising number of traumatic surgeries especially in pediatric patients has been reported in the past few decades, which is further expected to support the intraosseous infusion devices based market growth.

According to the Royal College of Surgeons, 2014, a document on emergency surgery policy briefing states that approximately 25% of patients were admitted in an emergency in 2012-2013 with 32% of trauma and orthopaedic surgery collectively. The rate of patient readmission increased by 27.1% from 2002-03 to reach 11.5% in 2012-13

The American College of Surgeons Advanced Trauma Life Support Manual (ATLS) 1997, has suggested the use of intraosseous infusion in children up to 6 years of age during traumatic situations like a circulatory failure or after two failed attempts of intravenous access.

What is the Impact of the COVID-19 Crisis on the Market?

Due to COVID 19, there has been a gradual rise in the market growth across intraosseous infusion devices segment. During the pandemic, there has been an increase in the number of emergency medical services where instant treatment was necessary. Furthermore, clinical conditions that needed instant care/ attention such as severe burns, accidents or trauma where IV access is not possible at that particular time and IO devices helps rapid infusion of fluids and medicines. This has let the demand for IO devices to boost. 

Narayana health org. in July 2020 stated that stroke can be a manifestation whilst covid-19 and 0.9% to 23% COVID-19 patients developed stroke. Hemorrhagic and ischemic stroke are the types of stroke seen in Covid-19 patients.

Country-wise Insights

Will the U.S. Intraosseous Infusion Devices Market Continue Leading North America?

In 2021, the U.S. is estimated to account for over 53.1% value share in North America. The demand is increasing in the U.S due to the increasing number of emergency medical cases that focus on delivering the highest quality and instant care to the patients.

Why is Russia Intraosseous Infusion Devices Market Considered Highly Lucrative within Europe?

Russia is expected to account for nearly 14.3% of the market in Europe. The rise in demand for intraosseous infusion devices in Russia is primarily due to the increasing aging population, rising cases of chronic diseases and presence of well-established centers which provide quality care. Furthermore, favorable regulatory scenarios are likely to offer exciting opportunities for the intraosseous infusion device in Russia.

What are the Factors Supporting Intraosseous Infusion Devices Sales in China?

The China market is expected to account for over 38.0% of the market share in East Asia through the forecast period. The increasing use of IO Devices, with advancement in technology, expansion of the healthcare industry, and the rising need for efficient and safe healthcare practices and other therapeutics are the primary factors driving growth in China.

Sales in China are also influenced by domestic market impact factors such as regulatory change, favorable government policies and growing funding which affects current and future market trends.

Category-wise Insights

Why is the demand for EZ-IO Product Rising?

In terms of product, EZ-IO intraosseous infusion devices hold the maximum share of over 20% in 2021, expanding at 7.6% CAGR during the forecast period. Growth registered in this category is due to its quick response and surety of easy intraosseous accessibility within 30 seconds.

Why is Sternum Route of Administration Preferred in Intraosseous Infusion Devices Market?

In terms of route of administration, the Sternum segment accounts for 30.8% of the market share in 2021, indicating prevalence of high demand for high-quality care specificity when compared with the Distal & Proximal Tibia. This trend is expected to continue during the forecast period as well.

How Will Sales of Automatic Intraosseous Infusion Devices Fare?

By technology, the automatic infusion devices market accounts for 50.8% of the market share in 2021. The demand in this segment will continue rising. It is primarily preferred by the patients when they need instant care.

Who is the Leading End User of Intraosseous Infusion Devices?

By end user, EMS and hospitals together will account for more than 60.0% of the market share in 2021.  The rising demand for IO devices with various advancements and harnessing new scientific advances is likely to fuel the segment.

Competitive Landscape

Companies manufacturing intraosseous infusion devices are actively seeking to strengthen their position through various strategic planning such as collaborations, merger & acquisition partnerships, FDA approvals and agreements with established as well as emerging market players. These strategies will help manufacturers capitalize on available opportunities in the market:

In July 2020, Aero Healthcare acquired Clayton First Aid creating a window where they can expand themselves into intraosseous infusion devices

The greater the demand for active service, the stronger is the end product, which will lead to increased demand for the market. Leading industry players are focusing on the development and launch of the technologically advanced service portfolio. There are huge opportunities for the market players to invest in intraosseous infusion device s

Scope of the Report

Intraosseous Infusion Devices - Market by Category

Product:

• B.I.G
• FAST1
• EZ-IO
• FASTR
• IO Needles
• Others

By Route of Administration:

• Sternum
• Distal & Proximal Tibia
• Distal Femur
• Calcaneus
• Head of Humerus

By Technology:

• Manual
• Automatic
  • Impact Driven
  • Power Drill

By End User:

• EMS
• Hospitals
• Ambulatory Surgical Centers
• Cardiac Care Centers

Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East and Africa (MEA)